EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns

Åsa Parke, Benedikt Strunz, Puran Chen, Karolinska Ki/K Covid-Study Group, Dorota Religa iD, Hans-Gustaf Ljunggren, Olav Rooyackers iD, Soo Aleman, Anna Norrby-Teglund iD, Niklas K Björkström iD, Magnus Hansson, Kristoffer Strålin iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27031243 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Åsa Parke und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Karolinska University Hospital, 141 57 Stockholm, Sweden. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, COVID-19, Proteome. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: (ALF Medicine), Centre for Innovative Medicine (CIMED), the Knut and Alice Wallenberg Foundation and Nordstjernan AB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calprotectin in blood has been identified as a potential biomarker for severe COVID-19 and sepsis. As a knowledge gap remains regarding the biological role of calprotectin, we aimed to investigate the association between serum calprotectin and the circulating proteome in patients with COVID-19 as a model for viral sepsis. In this observational study, serum samples were collected from 160 hospitalized adult patients with COVID-19. The samples were analyzed for calprotectin using a routine turbidimetric assay and for proteomics using the Olink Explore 1536 platform. Patients were classified as having severe or moderate COVID-19 according to oxygen supply on the day of blood sampling. The median calprotectin level was significantly higher in patients with severe compared to moderate COVID-19. In relation to proteomics, calprotectin levels were associated with a neutrophil-centered inflammatory proteomic signature, characterized by upregulation of cytokine and danger-signaling pathways. S100A12 showed the strongest correlation to calprotectin. In conclusion, calprotectin is associated with disease severity in COVID-19, and high levels reflect a neutrophil-driven inflammatory proteomic profile, particularly involving S100A12. These findings support calprotectin as a biomarker of neutrophil-mediated hyperinflammation in viral sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocyte L1 Antigen ComplexCOVID-19ProteomeHumansFemaleProteomicsBiomarkersMaleMiddle AgedAgedS100A12 ProteinSeverity of Illness IndexSARS-CoV-2AdultNeutrophilsHospitalizationSepsis

Stichwörter der Autor:innen

COVID-19COVID-19 severityS10012Aproteomicssepsisserum-calprotectin

Substanzen

Leukocyte L1 Antigen ComplexBiomarkersProteomeS100A12 ProteinS100A12 protein, human

Autor:innen und Institutionen

  • Department of Infectious Diseases, Karolinska University Hospital, 141 57 Stockholm, Sweden.
  • Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, 141 57 Stockholm, Sweden.
  • Department of Inflammation and Aging, Karolinska University Hospital, 141 57 Stockholm, Sweden.
  • Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, 171 77 Stockholm, Sweden.
  • Perioperative Medicine and Intensive Care, Karolinska University Hospital, 171 77 Stockholm, Sweden.
  • Department of Clinical Interventions and Technology, Karolinska Institutet, 171 77 Stockholm, Sweden.

ORCID-Profile: Dorota Religa, Olav Rooyackers, Anna Norrby-Teglund, Niklas K Björkström, Kristoffer Strålin

Förderung

  • (ALF Medicine)
  • Centre for Innovative Medicine (CIMED)
  • the Knut and Alice Wallenberg Foundation and Nordstjernan AB
  • Knut and Alice Wallenberg Foundation
  • Nordstjernan AB
  • Karolinska University Hospital
  • Region Stockholm

Zitieren

APA

Parke, Å., Strunz, B., Chen, P., Karolinska Ki/K Covid-Study Group, Religa, D., Ljunggren, H. G., Rooyackers, O., Aleman, S., Norrby-Teglund, A., Björkström, N. K., Hansson, M., & Strålin, K. (2026). Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031243

Vancouver

Parke Å, Strunz B, Chen P, Karolinska Ki/K Covid-Study Group, Religa D, Ljunggren HG, et al. Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031243

BibTeX
@article{Parke2026,
  author = {Parke, Åsa and Strunz, Benedikt and Chen, Puran and Karolinska Ki/K Covid-Study Group and Religa, Dorota and Ljunggren, Hans-Gustaf and Rooyackers, Olav and Aleman, Soo and Norrby-Teglund, Anna and Björkström, Niklas K and Hansson, Magnus and Strålin, Kristoffer},
  title = {Serum Calprotectin in Hospitalized Patients with COVID-19 in Relation to High-Dimensional Serum Proteomic Patterns},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27031243}
}
Kostenlos starten →